Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study.
Singh S, Rogers H, Kanber B, Clemente J, Pye H, Johnston EW, Parry T, Grey A, Dinneen E, Shaw G, Heavey S, Stopka-Farooqui U, Haider A, Freeman A, Giganti F, Atkinson D, Moore CM, Whitaker HC, Alexander DC, Panagiotaki E, Punwani S. Singh S, et al. Among authors: giganti f. Radiology. 2022 Dec;305(3):623-630. doi: 10.1148/radiol.212536. Epub 2022 Aug 2. Radiology. 2022. PMID: 35916679
Global Variation in Magnetic Resonance Imaging Quality of the Prostate.
Giganti F, Ng A, Asif A, Chan VW, Rossiter M, Nathan A, Khetrapal P, Dickinson L, Punwani S, Brew-Graves C, Freeman A, Emberton M, Moore CM, Allen C, Kasivisvanathan V; PRIME Quality Improvement Group. Giganti F, et al. Radiology. 2023 Oct;309(1):e231130. doi: 10.1148/radiol.231130. Radiology. 2023. PMID: 37815448 Clinical Trial.
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial.
Giganti F, Moore CM, Robertson NL, McCartan N, Jameson C, Bott SRJ, Winkler M, Gambarota G, Whitcher B, Castro R, Emberton M, Allen C, Kirkham A. Giganti F, et al. Eur Radiol. 2017 Nov;27(11):4767-4774. doi: 10.1007/s00330-017-4858-0. Epub 2017 May 18. Eur Radiol. 2017. PMID: 28523355 Free PMC article. Clinical Trial.
VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.
Johnston EW, Bonet-Carne E, Ferizi U, Yvernault B, Pye H, Patel D, Clemente J, Piga W, Heavey S, Sidhu HS, Giganti F, O'Callaghan J, Brizmohun Appayya M, Grey A, Saborowska A, Ourselin S, Hawkes D, Moore CM, Emberton M, Ahmed HU, Whitaker H, Rodriguez-Justo M, Freeman A, Atkinson D, Alexander D, Panagiotaki E, Punwani S. Johnston EW, et al. Among authors: giganti f. Radiology. 2019 May;291(2):391-397. doi: 10.1148/radiol.2019181749. Epub 2019 Apr 2. Radiology. 2019. PMID: 30938627 Free PMC article.
Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists.
Antonelli M, Johnston EW, Dikaios N, Cheung KK, Sidhu HS, Appayya MB, Giganti F, Simmons LAM, Freeman A, Allen C, Ahmed HU, Atkinson D, Ourselin S, Punwani S. Antonelli M, et al. Among authors: giganti f. Eur Radiol. 2019 Sep;29(9):4754-4764. doi: 10.1007/s00330-019-06244-2. Epub 2019 Jun 11. Eur Radiol. 2019. PMID: 31187216 Free PMC article.
MRI in early detection of prostate cancer.
Giganti F, Moore CM. Giganti F, et al. Curr Opin Urol. 2019 Nov;29(6):563-568. doi: 10.1097/MOU.0000000000000668. Curr Opin Urol. 2019. PMID: 31436569 Review.
ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training.
de Rooij M, Israël B, Tummers M, Ahmed HU, Barrett T, Giganti F, Hamm B, Løgager V, Padhani A, Panebianco V, Puech P, Richenberg J, Rouvière O, Salomon G, Schoots I, Veltman J, Villeirs G, Walz J, Barentsz JO. de Rooij M, et al. Among authors: giganti f. Eur Radiol. 2020 Oct;30(10):5404-5416. doi: 10.1007/s00330-020-06929-z. Epub 2020 May 19. Eur Radiol. 2020. PMID: 32424596 Free PMC article.
199 results